These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10348047)

  • 21. Semisynthetic modifications of hemiaminal function at ornithine unit of mulundocandin, towards chemical stability and antifungal activity.
    Lal B; Gund VG; Gangopadhyay AK; Nadkarni SR; Dikshit V; Chatterjee DK; Shirvaikar R
    Bioorg Med Chem; 2003 Nov; 11(23):5189-98. PubMed ID: 14604682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of A-192411.29, a novel antifungal lipopeptide.
    Nilius AM; Raney PM; Hensey-Rudloff DM; Wang W; Li Q; Flamm RK
    Antimicrob Agents Chemother; 2000 May; 44(5):1242-6. PubMed ID: 10770758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
    Komatsu M; Aihara M; Shimakawa K; Iwasaki M; Nagasaka Y; Fukuda S; Abe N; Matsuo S
    Jpn J Antibiot; 2003 Dec; 56(6):705-11. PubMed ID: 15007879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
    Kritikos A; Neofytos D; Khanna N; Schreiber PW; Boggian K; Bille J; Schrenzel J; Mühlethaler K; Zbinden R; Bruderer T; Goldenberger D; Pfyffer G; Conen A; Van Delden C; Zimmerli S; Sanglard D; Bachmann D; Marchetti O; Lamoth F;
    Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro.
    Jacobsen MD; Whyte JA; Odds FC
    Antimicrob Agents Chemother; 2007 May; 51(5):1882-4. PubMed ID: 17307974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial results from a longitudinal international surveillance programme for anidulafungin (2003).
    Messer SA; Kirby JT; Sader HS; Fritsche TR; Jones RN
    J Antimicrob Chemother; 2004 Dec; 54(6):1051-6. PubMed ID: 15564286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
    Ohta C; Yamane N; Nakasone I; Onaga S; Nakamura K
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P.
    Carrillo-Muñoz AJ; Ruesga M; Brio S; del Valle O; Rodriguez V; Santos P; Hernández-Molina JM; Cantón E; Pemán J; Guarro J; Quindós G
    Chemotherapy; 2002 Dec; 48(5):224-31. PubMed ID: 12476038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal activities and cytotoxicity studies of six new azasordarins.
    Herreros E; Almela MJ; Lozano S; Gomez de las Heras F; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3132-9. PubMed ID: 11600368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods.
    Lewis RE; Klepser ME; Pfaller MA
    Diagn Microbiol Infect Dis; 2000 Feb; 36(2):101-5. PubMed ID: 10705051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species.
    Chitty JL; Butler MS; Suboh A; Edwards DJ; Cooper MA; Fraser JA; Robertson AAB
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
    Cuenca-Estrella M; Mellado E; Díaz-Guerra TM; Monzón A; Rodríguez-Tudela JL
    J Antimicrob Chemother; 2000 Sep; 46(3):475-7. PubMed ID: 10980178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid determination of antifungal activity by flow cytometry.
    Green L; Petersen B; Steimel L; Haeber P; Current W
    J Clin Microbiol; 1994 Apr; 32(4):1088-91. PubMed ID: 8027319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
    Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
    J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The echinocandins.
    Cappelletty D; Eiselstein-McKitrick K
    Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
    Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
    Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.